CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects ofelectroacupuncture on
experimental arthritis of the rat temporomandibular joint.
Source
Medical Sciences Post-Graduation, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil. delanegondim@yahoo.com.br
Abstract
Electroacupuncture (EA) and cannabinoids have been reported to have anti-inflammatory and antinociceptiveeffects in animal models of arthritis. Male Wistar rats were injected with saline or zymosan (2 mg) into thetemporomandibular joint (TMJ). EA (10 Hz, 30 min) was performed 2 h after or 1 h before zymosan administration. AM251 or AM630 (3 mg/kg, i.p.)were administered before EA treatment. Mechanical hypernociception was accessed after zymosan administration. Rats were sacrificed 6 h after zymosan administration and the joint was removed for histopathological analysis. The gene expression of CB₁ and CB₂ receptors was assessed after sacrifice of the TMJ arthritic animals. EA inhibited zymosan-induced hypernociception (p < 0.05). AM251 reversed significantly the antinociceptive effect of EA, suggesting that the CB₁ receptor is involved in this effect. AM630 reversed the anti-inflammatory effect of EA. CB₁ and CB₂ receptor gene expression was upregulated 6 h after zymosan-induced arthritis in the EA-treated group. We observed downregulation of CB₂ receptor gene expression in the EA group at the 24th hour compared with the 6th hour. Higher CB₁ receptor gene expression was also found compared with the 6th hour. EA produced antinociceptive and anti-inflammatory effects, and these effects appeared to be mediated through CB₁ and CB₂ receptor activation.
- PMID:
23181276
[PubMed – indexed for MEDLINE]
MeSH Terms, Substances
MeSH Terms
- Acupuncture Analgesia/methods
- Animals
- Arthritis, Experimental/immunology
- Arthritis, Experimental/metabolism
- Arthritis, Experimental/prevention & control
- Arthritis, Experimental/therapy*
- Behavior, Animal/drug effects
- Down-Regulation
- Electroacupuncture*
- Indoles/pharmacology
- Male
- Nerve Tissue Proteins/antagonists & inhibitors
- Nerve Tissue Proteins/genetics
- Nerve Tissue Proteins/metabolism*
- Nociception/drug effects
- Piperidines/pharmacology
- Pyrazoles/pharmacology
- RNA, Messenger/metabolism
- Rats
- Rats, Wistar
- Receptor, Cannabinoid, CB1/antagonists & inhibitors
- Receptor, Cannabinoid, CB1/genetics
- Receptor, Cannabinoid, CB1/metabolism*
- Receptor, Cannabinoid, CB2/antagonists & inhibitors
- Receptor, Cannabinoid, CB2/genetics
- Receptor, Cannabinoid, CB2/metabolism*
- Temporomandibular Joint/drug effects
- Temporomandibular Joint/immunology*
- Temporomandibular Joint/innervation
- Temporomandibular Joint/pathology
- Trigeminal Nucleus, Spinal/drug effects
- Trigeminal Nucleus, Spinal/immunology
- Trigeminal Nucleus, Spinal/metabolism*
- Trigeminal Nucleus, Spinal/pathology
- Up-Regulation
- Zymosan
Substances
LinkOut – more resources
Full Text Sources
Other Literature Sources
Education